Managing Fibromyalgia: Supporting self-management brings many advantages
Managing Fibromyalgia: Supporting self-management brings many advantages
MANAGED CARE January 2011. ©MediMedia USA
Health plans can offer several kinds of assistance to physicians who are having trouble caring for these patients
It is not for every illness that the FDA recommends massage and emotional support. But fibromyalgia is not like most other illnesses. First, it should be said that there is no longer any question about whether fibromyalgia syndrome is a specific illness — the FDA itself states that these are patients who have gone through a change in the way their brains perceive pain.
And emotional support forms an essential element in management of this syndrome, according to the FDA. “Medication is just one part of the treatment approach” and the FDA also mentions walking, jogging, biking, gently stretching muscles, water therapy, massage, yoga, and other exercises.
Lyrica and Cymbalta and other pain relievers are not the only medications that the FDA considers relevant to fibromyalgia patients. Because comorbidities play a significant role, the FDA also considers sleep medications, antidepressants, muscle relaxants, and antiseizure medications.
But fibromyalgia patients should be approached with the assumption that no single modality alone is sufficient to address the syndrome, says Michael Siegel, MD, corporate vice president and medical director for utilization management and quality improvement at Molina Healthcare. Doctors, he says, should review the several approaches appropriate for the patient, explain each, and guide while at the same time empowering the patient.
A difficult condition
Is fibromyalgia a “legitimate or real” medical condition? I have asked myself this as a health plan medical director and as a primary care physician. The tendency among many of us has been that with the absence of biomarkers and minimal physical exam findings — tender points — fibromyalgia is the manifestation of a behavioral health condition. The question has been answered formally in that fibromyalgia has an ICD-9 CM code, is defined by authoritative medical references, and has FDA-approved medications with labeled indication for the treatment of fibromyalgia. And yet, in conversations with practicing physician colleagues and clinical executives from health plans, doubt remains. In my estimation, the point is moot. The facts or observations are that the constellation of signs and symptoms are found in as much as 4 percent of the adult population in the United States. That reality warrants health plans, provider organizations, practitioners, and employers to identify approaches to management that treat the symptoms and the underlying patho-physiological causes, whether psychological, neurological, immune-mediated, or otherwise.
Steven Peskin, MD, MBA, FACP
Executive Vice President, Chief Medical Officer
Many patients who are managing their illness effectively achieve a moderating of symptoms, says Connie Luedtke, RN, assistant professor of nursing at the Mayo Clinic Pain Rehabilitation Center and nursing supervisor of the Fibromyalgia & Chronic Fatigue Clinic at Mayo Clinic.
Speaking directly to the interests of health plan medical directors, Luedtke urges an attempt to achieve diagnosis at earlier stages of the illness and before patients respond to their symptoms by decreasing exercise and activities and become deconditioned. In her experience it takes an average of five years for primary care doctors to complete this diagnosis. The American College of Rheumatology says fibromyalgia develops in between 2 and 4 percent of the population, predominantly in women. So, prevalence is considerable and providers should be alert to the presence of the illness. Luedtke has treated patients who had to be started on a daily exercise regimen that lasted no more than two minutes!
Fibromyalgia remains challenging for clinicians because it generates tremendous amounts of friction between providers and patients. With fibromyalgia, as with similar conditions, “the biggest problem confronting the interaction between medical providers and patients is that patients fully expect that it will be more or less obvious what the problem is, and that modern medical science will have a way to fix it. And physicians, trapped in the same paradigm, feel they should be able to provide a discrete diagnosis and prescribe a discrete cure,” says Bill Clark, MD, past president of the American Academy on Communication in Healthcare and a lecturer in medicine at Harvard Medical School.
There are no simple answers. Providers have to work carefully to build trust and respect. What is important here is that how to do this can be learned. “Communication and interactional skills can be taught and learned,” says Clark. Modules 26 and 27 of the AACH’s “doc.com” project (http://www.aachonline.org) help physicians provide self-management support.
In most situations, giving emotional support is simple, Clark says. It amounts to actively noticing patients’ emotions and letting patients know you see or hear what they are experiencing, and that their uneasy and negative feelings about fibromyalgia are normal.
To convey emotional support, the academy advises:
- Make partnership statements. Make empathetic statements, naming patients’ emotions and communicating understanding and compassion.
- Make an apology, as this communicates concern for patients — for example, “I’m sorry I’m late,” “I’m sorry I offended / annoyed / ignored you,” or even, “I’m sorry you are ill, and I wish things were different,” Clark suggests.
- Show respect by validating in your own words patients’ choices, traits, and behaviors, even if you have to look for these. For example, you may respect actions patients have taken to manage the illness even if you consider them misguided. Patients’ persistence can be praised even as you provide correct information.
- Legitimize patients’ feelings and let them know it is pretty normal to be angry, worried, or sad about their fibromyalgia.
- Express support by conveying the message that “I will not abandon you. Even though I am referring you to see a specialist, I’m still going to be your doctor.”
Clark says to “Listen carefully and ask the patient to tell you more about what worries him and about how the fibromyalgia has been affecting daily life.” Interrupt if the patient goes on and on; patients want not only your attention, but also your expertise, Clark says. One study found physicians tend to interrupt patients’ opening statement after an average of 18 seconds; a more recent repeat study found that they did so after 23 seconds.
Molina Healthcare educates providers to use a shared decision-making model, says Siegel. Rather than saying, “This is what you should do,” the physician reviews the findings of the examination and test results with the patient and informs the patient about options. After a full discussion about what treatments might be used, the patient and physician decide together what the next steps are. “Often patients will choose the less aggressive option,” says Siegel.
There is a very high comorbidity of serious depression in fibromyalgia patients, points out Michael Golinkoff, PhD, MBA, chief clinical officer at Aetna Behavioral Health. He says that Aetna routinely screens for depression in these patients.
“Even with patients who do not meet diagnostic criteria for depression, we often find that there are many psychological symptoms present,” says Golinkoff. As fibromyalgia is “very stressing, very debilitating, addressing this suffering is an important part of the treatment plan.” Thus it is critical to refer patients as appropriate to psychotherapy and other associated treatments, Golinkoff says.
Golinkoff recommends the meta-analysis of psychological treatments for fibromyalgia by Julia A. Glombiewski et al in the journal Pain (2010; 151: 280–295), both the text and the incorporated references. This study found cognitive-behavioral therapy was associated with the greatest effect sizes and reports that “meta-analytic integration resulted in a significant but small effect size for short-term pain reduction (Hedges’s g = 0.37, 95 percent confidence interval (CI): 0.27–0.48) and a small-to-medium effect size for long-term pain reduction over an average follow-up phase of 7.4 months (Hedges’s g = 0.47, 95 percent CI: 0.3–0.49). Psychological treatments also proved effective in reducing sleep problems (Hedges’s g = 0.46, 95 percent CI: 0.28–0.64), depression (Hedges’s g = 0.33, 95 percent CI: 0.20–0.45), functional status (Hedges’s g = 0.42, 95 percent CI: 0.25–0.58), and catastrophizing (Hedges’s g = 0.33, 95 percent CI: 0.17–0.49).”
Notably these results are “comparable to those reported for other pain and drug treatments used for this disorder.”
Of course, this meta-analysis provides no statistics on the degree to which psychological treatments helped empower patients for self-management or how increased capacity for self-management affects patients’ frequency of physician visits and use of other expensive resources. However, the possibility that such relationships do exist might be kept in mind.
Group therapy as well as individual therapy has been shown to be effective, Golinkoff says. Siegel also emphasized the value of group sessions “if at all possible,” both because they help patients feel they’re not alone and because they provide an opportunity for them to learn from the experience of other fibromyalgia patients.
When patients receive individual or group therapy, “we find symptoms not necessarily associated with depression but associated directly with fibromyalgia improve,” Golinkoff says.
With some patients with fibromyalgia, biofeedback is extremely useful in helping them relax and become aware of when they are relaxed, Luedtke says. “Patients seem to love that.”
At Mayo Clinic, a 2.5-day program introduces fibromyalgia patients to the syndrome, although staffing is not large enough to enroll any but patients referred internally.
Some patients’ employers provide employee assistance programs and, if this is the case, Golinkoff says, it is often beneficial to integrate the resources of such a program into the care of this patient.
In selecting medications for these patients, it may be prudent to monitor carefully or avoid entirely medications that cause musculoskeletal pain, Siegel says, mentioning statins in particular.
What about fibromyalgia patients who look to unconventional approaches to manage their illness? Aetna offers eligible members who are interested in natural and complementary health care services access to many complementary health care services.
Even more important may be how providers address a patient’s wish to embark on some entirely unscientific activities — avoiding all sugar, for example. Too often the doctor’s stance is: I know the right answer, Clark says, although other approaches may be more productive in the long run. Keep in mind that the situation is not urgent. Focus on staying in a relationship with the patient and building a reserve of trust for the future. Understand the patient’s perspective. Support the patient’s determination to make the best decisions for herself, whether or not this perspective is very helpful — the physician has the expertise to explain there are other options.
Strengthening the physician-patient relationship is not only more effective for the patient but also may be more rewarding — and less frustrating — for the physician over the long run as well, Clark says. “Every patient wants a miracle cure and every doctor wants to prescribe it,” says Clark. “It is one thing to take out an appendix; it is another to wrestle with the symptoms and the mystery of fibromyalgia, an illness that is endlessly distressing for patients.”
Four ways to relate to fibromyalgia patients
Patients with fibromyalgia need to receive several things from their caregivers, says Connie Luedtke, RN, a nursing supervisor at the Mayo Clinic.
Medical directors may need to allow for more time for this patient population in medical practices. If patients feel that they have been listened to, that their experience has been validated, they are more likely to trust the recommendations that are given.
More time spent up front can save time on the end. Patients who don’t trust their providers are far more likely to keep using medical resources to find the cause of their symptoms and to keep searching for the so-called magical cure. Here are four ways to help patients that medical directors should know about.
First, let them know that the provider understands that their pain and fatigue are real. All too often they have been accused of being crazy or lazy or not wanting to work. Meanwhile many of them fear they have some far more devastating illnesses, as they perceive that they do not feel normal.
Second, explain to these patients that it is essential that they not wallow in their pain and fatigue. There is preliminary evidence that patients who dwell on their symptoms are generating more of the chemicals that create sensations of pain, she says, and her own experience is that patients on disability often do worse than those with a structured, productive life, even if this involves volunteer activities.
Third, they need a physician who will work with them, who will take them seriously and not be dismissive. This encompasses the provider’s understanding that as symptoms shift, the patients may want to know if they are developing some new condition.
Fourth, self-management is the key. Give them permission to take care of themselves. These are patients who need to live balanced and structured lives, so they do not overdo on good days and do not permit themselves to become deconditioned on bad days. Notably, she finds that patients who engage in relaxed, diaphragmatic breathing for 10 minutes three times a day are able to affect their levels of pain and fatigue.
Inasmuch as these patients need emotional support, according to the FDA, the provider-patient relationship occupies an important place in the therapeutic process. Many feel like victims and many are depressed, and the psychological overlay to this very real illness frequently affects severity. So, giving patients an opportunity to take an active approach to managing their illness is in itself therapeutic.
AACH a good place for clinicians to beef up communication skills
As physicians look to the American College of Cardiology to learn about cardiovascular medicine and to the American Academy of Neurology to learn about neurology, so to learn about improving relationships and communications with patients and providing support even in difficult situations, the American Academy on Communication in Healthcare is the place,” says Bill Clark, MD, past president of the academy and lecturer in medicine at Harvard Medical School.
Health plan medical directors might make use not only of the academy’s professional conferences but also the resources at www.AACHonline.org, where there is a multimedia learning system designed to help physicians “enhance skills furthering patient’s ability to handle uncertainty, grief, and suffering,” says Clark.
Physicians with expertise in physician-patient communications demonstrate skills in more than 400 unscripted videos.
Where doctors are not greatly skilled in relating to patients, the American Academy on Communications in Healthcare is “an excellent resource,” says Michael Siegel, MD, corporate VP and medical director for utilization management and quality improvement at Molina Healthcare.
Reach Bob Kirsch at email@example.com.
Group therapy has been shown to improve even nonpsychological symptoms.
The communication and interactional skills needed to deal with patients who have fibromyalgia can be taught and learned.
|Medical Devices Summit||Boston, MA||February 19–20, 2015|
|3rd Annual Summit to Improve Adherence and Enhance Patient Engagement||Philadelphia, PA||March 9–10, 2015|
|Value-Added Solutions for Enhanced Customer Experience||Philadelphia, PA||March 9, 2015|